Cite
HARVARD Citation
Prithviraj, P. et al. (n.d.). Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy. Journal for immunotherapy of cancer. p. . [Online].